Aura Biosciences, Inc.
AURA
$7.65
$0.000.00%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -68.91% | -22.57% | 1.06% | -24.18% | -32.86% |
| Total Depreciation and Amortization | -9.09% | -5.84% | -6.53% | -10.54% | -8.63% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 217.14% | 15.52% | 28.70% | 80.13% | 81.11% |
| Change in Net Operating Assets | -79.97% | -200.71% | 265.39% | -41.89% | 17.51% |
| Cash from Operations | -56.45% | -27.99% | 14.54% | -31.89% | -28.81% |
| Capital Expenditure | 46.15% | 45.45% | 41.14% | 86.80% | 92.57% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1,229.17% | 83.33% | 0.02% | -529.85% | -1.72% |
| Cash from Investing | -1,231.48% | 84.14% | 0.43% | -545.13% | 0.69% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 458.02% | 84.38% | 409.58% | 509.36% | 55,946.99% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -9.19% | -- | -- | -- | -- |
| Cash from Financing | 245.71% | 212.50% | 409.58% | 509.36% | 84,151.81% |
| Foreign Exchange rate Adjustments | -2,022.22% | -28.57% | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -124.53% | 286.93% | 90.30% | -1,181.36% | 1,721.42% |